Market overview
The global nebulizer market is worth USD 1.5 bn in 2026 and is forecast to reach USD 2.8 bn by 2036, growing at a 6.0% CAGR. United States is the largest country market and Compressor (jet) is the largest by product segment.
| Scope | Devices that turn liquid medicine into a fine mist for inhalation: compressor (jet), mesh, ultrasonic and breath-actuated nebulizers for home and clinical use. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.4 bn |
| Value 2026 | USD 1.5 bn |
| Value 2036 | USD 2.8 bn |
| CAGR 2026-2036 | 6.0% |
| Volume 2026 | 23.2 million units |
| Volume 2036 | 39.5 million units |
| Average price 2026 | USD 66.2 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Nebulizer market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.5 bn |
| 2027 | USD 1.6 bn |
| 2028 | USD 1.7 bn |
| 2029 | USD 1.8 bn |
| 2030 | USD 1.9 bn |
| 2031 | USD 2.1 bn |
| 2032 | USD 2.2 bn |
| 2033 | USD 2.3 bn |
| 2034 | USD 2.4 bn |
| 2035 | USD 2.6 bn |
| 2036 | USD 2.8 bn |
Nebulizer market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Compressor (jet) | 52.0% | 42.5% | USD 799 mn | 3.9% |
| Mesh | 30.0% | 41.0% | USD 461 mn | 9.4% |
| Ultrasonic | 12.0% | 11.3% | USD 184 mn | 5.4% |
| Breath-actuated and others | 6.0% | 5.1% | USD 92 mn | 4.4% |
By setting
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Home care | 58.0% | 63.0% | USD 891 mn | 6.9% |
| Hospitals | 30.0% | 25.7% | USD 461 mn | 4.4% |
| Clinics and ambulatory care | 12.0% | 11.3% | USD 184 mn | 5.4% |
By condition
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Asthma | 40.0% | 38.2% | USD 615 mn | 5.5% |
| COPD | 33.0% | 33.0% | USD 507 mn | 6.0% |
| Cystic fibrosis | 8.0% | 8.8% | USD 123 mn | 7.0% |
| Other respiratory conditions | 19.0% | 19.9% | USD 292 mn | 6.5% |
By technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Jet nebulizers | 40.0% | 34.0% | USD 615 mn | 4.3% |
| Ultrasonic nebulizers | 24.0% | 24.0% | USD 369 mn | 6.0% |
| Mesh nebulizers | 36.0% | 42.0% | USD 553 mn | 7.7% |
By portability
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Tabletop | 48.0% | 38.0% | USD 738 mn | 3.5% |
| Portable and handheld | 38.0% | 44.0% | USD 584 mn | 7.6% |
| Wearable and ventilator-integrated | 14.0% | 18.0% | USD 215 mn | 8.7% |
Top 25 countries for nebulizer by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 74.0% of 2026 revenue and the 25 countries below together hold 93.7%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 338 mn | 22.0% | USD 548 mn | 4.9% |
| 2 | China | USD 215 mn | 14.0% | USD 462 mn | 8.0% |
| 3 | Japan | USD 138 mn | 9.0% | USD 223 mn | 4.9% |
| 4 | Germany | USD 92 mn | 6.0% | USD 149 mn | 4.9% |
| 5 | India | USD 92 mn | 6.0% | USD 217 mn | 9.0% |
| 6 | France | USD 61 mn | 4.0% | USD 99 mn | 4.9% |
| 7 | United Kingdom | USD 61 mn | 4.0% | USD 99 mn | 4.9% |
| 8 | Brazil | USD 54 mn | 3.5% | USD 99 mn | 6.3% |
| 9 | Italy | USD 46 mn | 3.0% | USD 74 mn | 4.9% |
| 10 | South Korea | USD 38 mn | 2.5% | USD 69 mn | 6.0% |
| 11 | Spain | USD 37 mn | 2.4% | USD 90 mn | 9.2% |
| 12 | Mexico | USD 37 mn | 2.4% | USD 90 mn | 9.2% |
| 13 | Russia | USD 37 mn | 2.4% | USD 70 mn | 6.6% |
| 14 | Turkey | USD 37 mn | 2.4% | USD 56 mn | 4.2% |
| 15 | Australia | USD 30 mn | 2.0% | USD 46 mn | 4.2% |
| 16 | Canada | USD 25 mn | 1.6% | USD 37 mn | 4.2% |
| 17 | Indonesia | USD 20 mn | 1.3% | USD 31 mn | 4.2% |
| 18 | Poland | USD 17 mn | 1.1% | USD 25 mn | 4.1% |
| 19 | Egypt | USD 15 mn | 1.0% | USD 22 mn | 4.2% |
| 20 | Vietnam | USD 13 mn | 0.8% | USD 19 mn | 4.2% |
| 21 | Thailand | USD 10 mn | 0.7% | USD 15 mn | 4.1% |
| 22 | Pakistan | USD 8.4 mn | 0.6% | USD 13 mn | 4.1% |
| 23 | Saudi Arabia | USD 6.6 mn | 0.4% | USD 10 mn | 4.4% |
| 24 | Argentina | USD 5.7 mn | 0.4% | USD 8.5 mn | 4.1% |
| 25 | Netherlands | USD 4.3 mn | 0.3% | USD 6.6 mn | 4.4% |
| Rest of world | USD 96 mn | 6.3% | USD 173 mn | 6.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Philips
- Omron Healthcare
- PARI
Group 2: Regional and specialist players
- Yuwell
- Drive DeVilbiss Healthcare
- Beurer
- Medel
- Feellife Health
- Briggs Healthcare
- Salter Labs
- Flexicare Medical
- A and D Medical
Group 3: Emerging and niche players
- Aerogen
- Microlife
- Rossmax
- HCmed Innovations
- Trudell Medical International
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the nebulizer market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.0% is calculated from the resulting values.
The market is divided by product, by setting, by condition, by technology, by portability. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the nebulizer market?
The global nebulizer market is estimated at USD 1.4 bn in 2025 and USD 1.5 bn in 2026.
How fast will the nebulizer market grow?
It is forecast to reach USD 2.8 bn by 2036, a compound annual growth rate of 6.0% from 2026, an increase of USD 1.2 bn.
Which country is the largest market for nebulizer?
United States is the largest market by revenue at USD 338 mn in 2026, 22.0% of the global total. The three largest countries together hold 45.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 9.0% a year from 2026 to 2036.
Which nebulizer segment is largest?
In the by product split, Compressor (jet) is the largest segment with 52.0% of 2026 revenue.
Who are the leading nebulizer companies?
Global leaders include Philips, Omron Healthcare, PARI.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Animal Immunoassay KitsUSD 1.5 bn · 7.0% CAGR
- Vascular Thromboembolic Disease ThrombectomyUSD 1.5 bn · 13.0% CAGR
- Rubber StopperUSD 1.6 bn · 6.3% CAGR
- Animal Wound CareUSD 1.6 bn · 7.0% CAGR
- IsolatorUSD 1.5 bn · 8.2% CAGR
- 3D Imaging Surgical SolutionUSD 1.5 bn · 8.5% CAGR
- Neurosurgery & Spine RobotsUSD 1.4 bn · 12.0% CAGR
- Microplate ReaderUSD 1.7 bn · 6.5% CAGR